Oak Harbor Wealth Partners LLC boosted its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 7.4% in the third quarter, HoldingsChannel reports. The firm owned 9,156 shares of the financial services provider’s stock after purchasing an additional 629 shares during the period. Oak Harbor Wealth Partners LLC’s holdings in CME Group were worth $2,020,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Y.D. More Investments Ltd purchased a new stake in CME Group in the 2nd quarter worth about $36,000. McClarren Financial Advisors Inc. lifted its position in CME Group by 66.1% in the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after buying an additional 78 shares during the last quarter. Asset Dedication LLC lifted its position in CME Group by 515.2% in the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 170 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. increased its stake in shares of CME Group by 62.2% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after buying an additional 74 shares during the period. Finally, Bank & Trust Co purchased a new position in shares of CME Group during the second quarter valued at approximately $76,000. Institutional investors own 87.75% of the company’s stock.
Insider Transactions at CME Group
In related news, Director Timothy S. Bitsberger sold 1,000 shares of CME Group stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $226.96, for a total value of $226,960.00. Following the completion of the transaction, the director now owns 10,589 shares in the company, valued at approximately $2,403,279.44. This trade represents a 8.63 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 12.01 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 15,621 shares of company stock valued at $3,441,063. 0.30% of the stock is currently owned by corporate insiders.
CME Group Stock Performance
CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.03. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm’s revenue was up 18.4% on a year-over-year basis. During the same period in the previous year, the firm posted $2.25 EPS. On average, sell-side analysts anticipate that CME Group Inc. will post 10.23 EPS for the current year.
CME Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.06%. The ex-dividend date is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is presently 48.37%.
Analyst Ratings Changes
Several equities research analysts recently commented on the company. Barclays increased their price objective on CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a research report on Thursday, October 24th. Bank of America boosted their price target on CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research report on Thursday, October 3rd. Deutsche Bank Aktiengesellschaft lowered their target price on CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research note on Monday. Keefe, Bruyette & Woods increased their price target on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Finally, Redburn Atlantic lowered CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price for the company. in a report on Tuesday, October 8th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $224.47.
Read Our Latest Stock Analysis on CME
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
- Five stocks we like better than CME Group
- P/E Ratio Calculation: How to Assess Stocks
- Why Meta Should Rally All The Way Into 2025
- How to Invest in Small Cap StocksĀ
- 3 High-Yields Unfazed by the Election: Altria, Truist, Verizon
- High Flyers: 3 Natural Gas Stocks for March 2022
- Q3 Earnings Indicate On Holdings May Outperform Lululemon in 2024
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.